J.M. Gornet

1.4k total citations
24 papers, 801 citations indexed

About

J.M. Gornet is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, J.M. Gornet has authored 24 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Surgery and 8 papers in Genetics. Recurrent topics in J.M. Gornet's work include Colorectal Cancer Treatments and Studies (8 papers), Inflammatory Bowel Disease (8 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). J.M. Gornet is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Inflammatory Bowel Disease (8 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). J.M. Gornet collaborates with scholars based in France, United States and Belgium. J.M. Gornet's co-authors include Marc Lémann, François Goldwasser, Yoram Bouhnik, R Modigliani, Jacques Cosnes, J. Alexandre, Bruno Falissard, J.L. Misset, Thomas Aparicio and Iradj Sobhani and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

J.M. Gornet

23 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Gornet France 11 359 284 182 177 140 24 801
Calogero Cipolla Italy 18 242 0.7× 526 1.9× 209 1.1× 56 0.3× 77 0.6× 90 1.0k
Junji Yokoyama Japan 19 131 0.4× 492 1.7× 201 1.1× 121 0.7× 174 1.2× 99 959
M Latteri Italy 20 318 0.9× 432 1.5× 164 0.9× 51 0.3× 120 0.9× 76 1.0k
Jung Ho Park South Korea 14 461 1.3× 434 1.5× 358 2.0× 57 0.3× 106 0.8× 37 922
Mehmet İbi̇ş Türkiye 14 163 0.5× 262 0.9× 104 0.6× 74 0.4× 151 1.1× 41 556
Deniz Tural Türkiye 17 478 1.3× 217 0.8× 377 2.1× 43 0.2× 89 0.6× 121 938
Doğan Uncu Türkiye 15 348 1.0× 161 0.6× 261 1.4× 45 0.3× 45 0.3× 96 704
Peter P. Stanich United States 15 268 0.7× 354 1.2× 213 1.2× 78 0.4× 154 1.1× 71 796
P. Frühmorgen Germany 17 469 1.3× 468 1.6× 427 2.3× 86 0.5× 87 0.6× 93 1.0k
Shigeyuki Yoshiyama Japan 21 528 1.5× 483 1.7× 293 1.6× 143 0.8× 158 1.1× 70 1.2k

Countries citing papers authored by J.M. Gornet

Since Specialization
Citations

This map shows the geographic impact of J.M. Gornet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Gornet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Gornet more than expected).

Fields of papers citing papers by J.M. Gornet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Gornet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Gornet. The network helps show where J.M. Gornet may publish in the future.

Co-authorship network of co-authors of J.M. Gornet

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Gornet. A scholar is included among the top collaborators of J.M. Gornet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Gornet. J.M. Gornet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reenaers, Cathérine, Maria Nachury, David Laharie, et al.. (2024). DOP23 The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort. Journal of Crohn s and Colitis. 18(Supplement_1). i117–i117. 1 indexed citations
2.
Rusquec, Pauline du, Rosine Guimbaud, Karine Le Malicot, et al.. (2023). Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens. ESMO Open. 8(4). 101616–101616. 1 indexed citations
3.
Hammoudi, Nassim, Jacqueline Lehmann‐Che, Jérôme Lambert, et al.. (2023). Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center. Digestive and Liver Disease. 55(9). 1280–1287. 2 indexed citations
4.
Gornet, J.M., et al.. (2020). What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?. Journal of Visceral Surgery. 157(3). S51–S57. 2 indexed citations
5.
Kirchgesner, Julien, Jérôme Lambert, Catherine Thiéblemont, et al.. (2020). Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study. Journal of Crohn s and Colitis. 14(9). 1222–1230. 6 indexed citations
6.
Abboud, K., Thierry André, Michel Ducreux, et al.. (2019). Management of colorectal peritoneal metastases: Expert opinion. Journal of Visceral Surgery. 156(5). 377–379. 21 indexed citations
7.
Abboud, K., Thierry André, Michel Ducreux, et al.. (2019). Accord d’experts français pour la prise en charge des métastases péritonéales de cancers colo-rectaux. Journal de Chirurgie Viscérale. 156(5). 412–415. 1 indexed citations
8.
Touchefeu, Yann, Rosine Guimbaud, Christophe Louvet, et al.. (2018). Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial. Gastric Cancer. 22(3). 577–586. 5 indexed citations
9.
Cohen, Romain, Olivier Buhard, Pascale Cervera, et al.. (2017). Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. European Journal of Cancer. 86. 266–274. 66 indexed citations
10.
Simon, M., Jacques Cosnes, J.M. Gornet, et al.. (2016). Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients. Journal of Crohn s and Colitis. 11(1). 47–52. 19 indexed citations
11.
Baroudjian, Barouyr, Marianne Maillet, P Bertheau, et al.. (2016). Un nouveau mécanisme de colite sous anti-PD1. Annales de Dermatologie et de Vénéréologie. 143(12). S351–S352.
12.
Durand, Jean-Philippe, G. Deplanque, J.M. Gornet, et al.. (2011). Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Annals of Oncology. 23(1). 200–205. 144 indexed citations
13.
Zaanan, Aziz, M. Gauthier, David Malka, et al.. (2010). Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study. Annals of Oncology. 21(9). 1786–1793. 103 indexed citations
14.
Amrouche, Lucile, J.M. Gornet, C. Lascoux, et al.. (2009). De la fibrose rétropéritonéale à la linite gastrique. La Revue de Médecine Interne. 30(5). 443–445. 4 indexed citations
15.
Sobhani, Iradj, Emmanuel Tiret, Rachida Lebtahi, et al.. (2008). Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. British Journal of Cancer. 98(5). 875–880. 85 indexed citations
16.
Cosnes, Jacques, et al.. (2005). Impact of pregnancy on the clinical activity of Crohn's disease. Alimentary Pharmacology & Therapeutics. 21(5). 509–513. 46 indexed citations
17.
Gornet, J.M., J C Delchier, Philippe Marteau, et al.. (2003). Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study. Alimentary Pharmacology & Therapeutics. 18(2). 175–181. 80 indexed citations
18.
Sabaté, J M, J. Villarejo, Yoram Bouhnik, et al.. (2003). Hydrostatic balloon dilatation of Crohn's strictures. Alimentary Pharmacology & Therapeutics. 18(4). 409–413. 79 indexed citations
19.
Gornet, J.M., Éric Savier, François Lokiec, et al.. (2002). Exacerbation of oxaliplatin neurosensory toxicity following surgery. Annals of Oncology. 13(8). 1315–1318. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Calogero Cipolla Breakdown of academic impact, for papers by Junji Yokoyama Breakdown of academic impact, for papers by M Latteri Breakdown of academic impact, for papers by Jung Ho Park Breakdown of academic impact, for papers by Mehmet İbi̇ş Breakdown of academic impact, for papers by Deniz Tural Breakdown of academic impact, for papers by Doğan Uncu Breakdown of academic impact, for papers by Peter P. Stanich Breakdown of academic impact, for papers by P. Frühmorgen Breakdown of academic impact, for papers by Shigeyuki Yoshiyama
Rankless by CCL
2026